Can low total IgM weaken early antibody surveillance and raise infection risk?

Low total IgM is most clinically relevant when it is persistent and accompanies recurrent infections or deficient functional antibody responses, rather than as an isolated laboratory finding.

Clinical evidence

• Adult cohorts with selective/isolated IgM deficiency report frequent recurrent or chronic sinopulmonary infection. In 48 symptomatic adults, 60% had recurrent/chronic respiratory infections; another series reported rhinosinusitis in 53%, recurrent pneumonia in 17%, and otitis media in 11%.
• In a 62-adult cohort, 73% reported recurrent or chronic respiratory infections—including sinusitis, bronchitis, and pneumonia—and 16% had recurrent urinary infections.
• The association is heterogeneous. In a laboratory cohort, only 42 adults had confirmed persistent primary isolated IgM deficiency, and 28% of initially asymptomatic individuals developed potentially related symptoms during follow-up.

Mechanistic rationale

• Natural IgM provides broad, pre-existing antimicrobial recognition before high-affinity adaptive IgG responses develop. Antigen-bound IgM recruits C1q and activates C1r/C1s, initiating the classical complement pathway.
• Downstream C3 deposition opsonizes microbes, facilitating complement-receptor-mediated phagocytic uptake. Thus, inadequate functional IgM could plausibly compromise early agglutination, complement-mediated clearance, and containment of infection.
• Functional defects may be more informative than concentration alone: approximately 45–47% of tested adults with IgM deficiency had impaired pneumococcal-specific antibody responses.

Clinical interpretation

• A low total IgM result alone does not establish impaired microbial binding, complement activation, or infection risk in a particular person. Its significance depends on infection history, repeated immunoglobulin measurements, IgG/IgA and IgG subclasses, vaccine-specific antibody responses, lymphocyte phenotyping, medications, and exclusion of secondary causes.

Bottom line

• Low total IgM is a moderate-confidence marker of increased susceptibility to recurrent or persistent infections in a clinically affected subset—especially recurrent respiratory disease with impaired pneumococcal responses—while its effect on early antibody surveillance remains biologically plausible but cannot be inferred from serum IgM concentration alone.